Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.7K
Introduction to Hemostasis01:05

Introduction to Hemostasis

9.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.4K
Coagulation01:09

Coagulation

7.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.7K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

975
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
975
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

5.3K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation management and monitoring in ECMO: an international survey: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.

Research and practice in thrombosis and haemostasis·2026
Same author

Effectiveness of a Streamlined Educational Experience: Improving Resident Medical Knowledge and Comfort Level in Pediatric Hematology and Oncology.

Journal of cancer education : the official journal of the American Association for Cancer Education·2025
Same author

Navigating coagulation: Key markers in the first 24 hours of pediatric ECMO.

Perfusion·2025
Same author

Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what's new on the horizon?

Expert opinion on pharmacotherapy·2024
Same author

Balancing anticoagulation and hemostasis in an infant with severe hemophilia A during cardiac transplantation: Review of the literature and development of a surgical protocol.

Pediatric blood & cancer·2023
Same author

Juvenile Hemochromatosis in an Asymptomatic Patient-Importance of Early Diagnosis.

JPGN reports·2023

Related Experiment Video

Updated: Oct 5, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.2K

Developmental Hemostasis: The Evolution of our Coagulation System.

Gianna M Guzzardo1, Katherine Regling1,2

  • 1Department of Pediatric Hematology Oncology, Children's Hospital of Michigan, Detroit, MI.

Neoreviews
|February 1, 2022
PubMed
Summary

Neonatal hemostasis differs significantly from adult coagulation, with lower factor levels and unique reference ranges. Understanding these developmental changes is crucial for diagnosing and treating bleeding or clotting disorders in infants.

More Related Videos

Author Spotlight: Studying hiPSC-Derived Endothelial Cells Cultured Under Fluidic-Mediated Mechanical Stimulation
09:12

Author Spotlight: Studying hiPSC-Derived Endothelial Cells Cultured Under Fluidic-Mediated Mechanical Stimulation

Published on: July 28, 2023

1.8K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Related Experiment Videos

Last Updated: Oct 5, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.2K
Author Spotlight: Studying hiPSC-Derived Endothelial Cells Cultured Under Fluidic-Mediated Mechanical Stimulation
09:12

Author Spotlight: Studying hiPSC-Derived Endothelial Cells Cultured Under Fluidic-Mediated Mechanical Stimulation

Published on: July 28, 2023

1.8K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Area of Science:

  • Hematology
  • Pediatrics
  • Coagulation Science

Background:

  • Neonates exhibit distinct coagulation profiles compared to adults, characterized by lower coagulation factor levels and higher screening test results.
  • Factors such as gestational age, labor, and clinical condition can influence neonatal hemostasis.
  • Interpreting standard coagulation screening tests (prothrombin time, partial thromboplastin time, fibrinogen) in neonates is challenging due to age-specific laboratory reference ranges.

Purpose of the Study:

  • To elucidate the concept of developmental hemostasis, outlining the coagulation system's maturation from infancy to adulthood.
  • To highlight the importance of understanding neonatal hemostasis for accurate clinical evaluation and management.
  • To provide an overview of diagnostic and therapeutic considerations in pediatric coagulation.

Main Methods:

  • Review of existing literature on neonatal and pediatric coagulation.
  • Analysis of common coagulation screening tests and their interpretation in different age groups.
  • Discussion of clinical implications and management strategies for hemostatic disorders in neonates.

Main Results:

  • Neonates possess a unique hemostatic system with lower coagulation factor levels and altered screening test results.
  • Age-specific reference ranges are essential for interpreting coagulation tests in neonates.
  • Developmental hemostasis impacts the diagnosis and treatment of conditions like vitamin K deficiency, surgical bleeding, infections, and inherited thrombotic or bleeding disorders.

Conclusions:

  • A comprehensive understanding of developmental hemostasis is critical for effective pediatric hematology practice.
  • Accurate interpretation of coagulation tests requires consideration of age-specific norms.
  • Appropriate management of neonatal bleeding (platelets, fresh frozen plasma) and thrombosis (heparinoids) is guided by developmental hemostatic principles.